Dr. Eric B. Kmiec is widely recognized for his pioneering work in the fields of molecular medicine and gene repair. Throughout his professional career, Dr. Kmiec led research teams in developing genetic therapies for inherited disorders such as Sickle Cell Disease. He is the recipient of multiple research awards from the National Institutes of Health, the American Cancer Society, and private foundations including the 2012 Proudford Foundation Unsung Hero Research Award. He has authored over 140 scientific publications, holds eighteen issued and licensed patents, and has founded two biotechnology companies; Kimeragen and OrphageniX. Dr. Kmiec is highly respected as a teacher and mentor to undergraduate students, graduate students and postdoctoral fellows, almost all of whom have followed in his footsteps and currently also work in the area of genetic medicine. Dr. Kmiec became Chairman of the Department of Chemistry at Delaware State University in 2011 after being honored as an Eminent Scholar at Marshall University in 2008, where he was also the founding director of the Marshall Institute for Interdisciplinary Research. Dr. Kmiec earned his Ph.D. from the University of Florida and has held professorships at the University of California at Davis, Thomas Jefferson University and the University of Delaware.